A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

Nature

Volumn 404, Issue 6773, 2000, Pages 42-49

  Tanaka, Hiroshi ^a   Arakawa, Hirofumi ^a   Yamaguchi, Tatsuya ^a   Shiraishi, Kenji ^a   Fukuda, Seisuke ^a   Matsui, Kuniko ^a   Takei, Yoshiki ^a   Nakamura, Yusuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA; DOXORUBICIN; MESSENGER RNA; PROTEIN P53; RIBONUCLEOTIDE REDUCTASE; TOXIN;

ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GAMMA IRRADIATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; CELL CYCLE; CELL CYCLE PROTEINS; DNA DAMAGE; DNA REPAIR; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENS; RIBONUCLEOTIDE REDUCTASES; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034594978     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35003506     Document Type: Article

References (22)

1. Greenblatt, M. S., Bennett, W. P., Hollstein, M. & Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878 (1994).
2. el-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinder, K. W. & Vogelstein, B. Definition of a consensus binding site for p53. Nature Genet. 1, 45-49 (1992).
3. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
4. el-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
5. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993).
6. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J. & Leder, P. Mice lacking p21CIPI/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684 (1995).
7. Brugarolas, J. et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552-557 (1995).
8. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
9. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V. & Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad. Sci. USA 89, 7491-7495 (1992).
10. Lane, D. P. Cancer. p53, guardian of the genome. Nature 358, 15-16 (1992).
11. Ford, J. M. & Hanawalt, P. C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl Acad. Sci. USA 92, 8876-8880 (1995).
12. Ford, J. M. & Hanawalt, P. C. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem. 272, 28073-28080 (1997).
13. Smith, M. L. & Fornace, A. J. Jr p53-mediated protective responses to UV irradiation. Proc. Natl Acad. Sci. USA 94, 12255-12257 (1997).
14. Eller, M. S., Maeda, T., Magnoni, C., Atwal, D. & Gilchrest, B. A. Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc. Natl Acad. Sci. USA 94, 12627-12632 (1997).
15. Hawkins, D. S., Demers, G. W. & Galloway, D. A. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res. 56, 892-898 (1996).
16. Ceraline, J. et al. Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents. Int. J. Cancer 75, 432-433 (1998).
17. Furuhata, T., Tokino, T., Urano, T. & Nakamura, Y. Isolation of a novel GPI-anchored gene specifically regulated by p53; correlation between its expression and anti-cancer drug sensitivity. Oncogene 13, 1965-1970 (1996).
18. Urano, T. et al. Cloning of P2XM, a novel human P2X receptor gene regulated by p53. Cancer Res. 57, 3281-3287 (1997).
19. Nishimori, H. et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 15, 2145-2150 (1997).
20. Han, H. J., Tokino, T. & Nakamura, Y. CSR, a scavenger receptor-like protein with a protective role against cellular damage caused by UV irradiation and oxidative stress. Hum. Mol. Genet. 7, 1039-1046 (1998).
21. Tokino, T. et al. p53 tagged sites from human genomic DNA. Hum. Mol. Genet. 3, 1537-1542 (1994).
22. Liang, P. & Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967-971 (1992).